Vesalius Longevity Labs Inc.

New Filing

CIK: 0002131865·Pharmaceuticals·BRITISH COLUMBIA, CANADA·Filed: Nov 3, 2026

Total Offering

$30,112,500

Amount Sold

$30,112,500

Investors

62

First Sale

Oct 28, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
PRADEEP ALBERT	Related Person
CHRISTOPHER R COOPER	Related Person
TIMMI STUMP	Related Person
JAMES MCROBERTS	Related Person
KEVIN SERRE	Related Person
ROBERT MCCUE	Related Person
JOEL LEONOFF	Related Person
KEVIN MAYER	Related Person
DAVID ADELMAN	Related Person
LEE APPLBAUM	Related Person

Company

Vesalius Longevity Labs Inc.

SUITE 1500-1055 WEST GEORGIA STREET

VANCOUVER, A1, V6E 4N7

604-307-8290

SEC Filing

0002060755-26-000064

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.